GLENMARK PHARMACEUTICALS LTD. (GLENMARK)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 3,373.72 3,401.60 3,207.38 2,506.70 3,062.95 3,244.19 3,433.80 3,387.55 3,256.21 3,264.44 6,046.87 3,900.62
YOY Revenue Growth % 11.74% 22.48% -4.97% -27.63% -9.21% -4.63% 7.06% 35.14% 6.31% 0.62% 76.1% 15.15%
Other Income -40.21 20.87 1.70 45.41 773.17 31.49 39.42 31.13 11.69 26.44 200.63 44.47
Total Income 3,333.50 3,422.48 3,209.07 2,552.11 3,836.12 3,275.68 3,473.21 3,418.68 3,267.89 3,290.88 6,247.50 3,945.08
Total Expenses + 2,453.43 2,474.52 2,463.06 2,340.60 2,317.39 2,231.67 2,536.16 2,449.45 2,887.10 2,872.07 3,894.98 3,226.74
Cost of Materials Consumed 876.80 932.13 915.75 657.51 754.31 685.77 774.36 746.37 794.78 732.47 722.50 775.30
Employee Benefit Expense 657.58 729.41 732.88 753.04 700.96 710.44 786.57 788.49 736.57 762.75 1,086.26 841.40
Other Expenses 919.06 812.99 814.43 930.05 862.13 835.45 975.24 914.60 869.66 905.59 1,336.56 894.37
Operating Profit 920.28 927.09 744.32 166.11 745.56 1,012.52 897.63 938.10 369.11 392.37 2,151.89 673.87
OPM % 27.3% 27.3% 23.2% 6.6% 24.3% 31.2% 26.1% 27.7% 11.3% 12% 35.6% 17.3%
Profit Before Tax + -490.77 333.41 -124.36 -521.38 530.83 462.33 472.57 456.33 7.97 95.58 967.40 534.00
Tax Expense -87.63 160.28 -60.80 -190.57 1,745.10 122.10 118.09 108.30 3.59 48.61 356.97 130.77
Tax % - 48.1% - - 328.7% 26.4% 25% 23.7% 45% 50.9% 36.9% 24.5%
Profit After Tax -403.14 173.13 -63.55 -330.82 -1,214.27 340.24 354.49 348.03 4.38 46.97 610.43 403.23
EPS (Basic) -15.18 5.31 -2.90 -12.45 -43.18 12.06 12.55 12.33 0.16 1.66 21.63 14.29

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 13,321.74 11,813.10 12,990.11 12,304.90 10,943.93 10,640.97 9,865.47
YOY Revenue Growth % 12.77% -9.06% 5.57% 12.44% 2.85% 7.86% -
Other Income 113.72 839.99 316.79 166.67 50.22 159.60 208.14
Total Income 13,435.46 12,653.09 13,306.90 12,471.58 10,994.15 10,800.57 10,073.61
Total Expenses + 11,663.43 9,362.22 9,768.58 8,878.08 8,298.53 7,785.72 7,362.04
Cost of Materials Consumed 3,001.27 3,157.82 3,593.79 3,278.76 3,137.81 2,541.47 2,444.71
Employee Benefit Expense 3,022.06 2,868.14 2,780.96 2,447.42 2,343.71 2,254.78 2,056.07
Other Expenses 3,594.96 3,336.25 3,393.83 3,151.90 2,817.02 2,989.47 2,861.26
Operating Profit 1,658.31 2,450.88 3,221.53 3,426.83 2,645.40 2,855.25 2,503.43
OPM % 12.4% 20.7% 24.8% 27.8% 24.2% 26.8% 25.4%
Profit Before Exceptional 1,772.03 937.45 1,634.31 1,702.16 1,337.93 1,063.20 1,133.45
Exceptional Items -372.82 -900.96 -765.85 -260.91 44.55 32.88 167.18
Profit Before Tax + 1,399.21 36.50 868.45 1,441.25 1,382.48 1,096.08 1,300.63
Tax Expense 352.07 1,470.02 491.05 447.60 412.39 320.11 375.64
Tax % 25.2% 4028% 56.5% 31.1% 29.8% 29.2% 28.9%
Profit After Tax 1,047.14 -1,433.52 377.40 993.65 970.09 775.97 924.99
EPS (Basic) 37.11 -53.22 10.53 33.37 34.38 27.50 32.78

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 6,754.09 6,930.54 9,497.96 0.00 0.00 0.00 0.00
Property, Plant & Equipment 3,319.37 3,118.15 3,904.16 0.00 0.00 0.00 0.00
Capital Work in Progress 541.99 419.32 1,115.18 0.00 0.00 0.00 0.00
Non-Current Investments 56.36 789.66 44.65 0.00 0.00 0.00 0.00
Goodwill 70.27 67.36 73.62 0.00 0.00 0.00 0.00
Other Intangible Assets 1,097.19 1,024.65 2,224.61 0.00 0.00 0.00 0.00
Current Assets + 9,295.47 7,428.08 9,873.72 0.00 0.00 0.00 0.00
Inventories 3,028.53 2,513.05 2,977.79 0.00 0.00 0.00 0.00
Trade Receivables 3,341.95 1,858.41 4,098.61 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 1,675.71 1,658.27 1,443.03 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 28.22 28.22 28.22 0.00 0.00 0.00 0.00
Other Equity 8,821.22 7,819.71 9,445.71 0.00 0.00 0.00 0.00
Non-Current Liabilities 1,233.46 692.49 4,486.89 0.00 0.00 0.00 0.00
Current Liabilities 5,967.02 5,818.59 5,045.53 0.00 0.00 0.00 0.00
Total Liabilities 7,200.48 6,511.08 9,532.42 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities -827.60 -265.44 625.39 1,108.65 0.00 0.00 0.00
Cash from Investing Activities 2.09 4,369.14 -528.49 -333.28 0.00 0.00 0.00
Cash from Financing Activities 787.05 -3,906.13 -77.46 -520.49 0.00 0.00 0.00
Net Increase/Decrease in Cash 17.44 215.24 32.50 272.43 0.00 0.00 0.00